rs61755362

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000640252.2(PIGN):​c.167C>T​(p.Ala56Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,613,728 control chromosomes in the GnomAD database, including 212 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A56T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.011 ( 34 hom., cov: 33)
Exomes 𝑓: 0.012 ( 178 hom. )

Consequence

PIGN
ENST00000640252.2 missense

Scores

8
6
4

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 9.94
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011676133).
BP6
Variant 18-62161187-G-A is Benign according to our data. Variant chr18-62161187-G-A is described in ClinVar as [Benign]. Clinvar id is 447939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-62161187-G-A is described in Lovd as [Likely_benign]. Variant chr18-62161187-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0106 (1620/152288) while in subpopulation NFE AF= 0.0125 (847/68028). AF 95% confidence interval is 0.0118. There are 34 homozygotes in gnomad4. There are 924 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 34 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PIGNNM_176787.5 linkuse as main transcriptc.167C>T p.Ala56Val missense_variant 4/31 ENST00000640252.2 NP_789744.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkuse as main transcriptc.167C>T p.Ala56Val missense_variant 4/311 NM_176787.5 ENSP00000492233 P1

Frequencies

GnomAD3 genomes
AF:
0.0107
AC:
1621
AN:
152170
Hom.:
34
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.0558
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0124
Gnomad OTH
AF:
0.00910
GnomAD3 exomes
AF:
0.0123
AC:
3073
AN:
249062
Hom.:
42
AF XY:
0.0125
AC XY:
1684
AN XY:
135108
show subpopulations
Gnomad AFR exome
AF:
0.00168
Gnomad AMR exome
AF:
0.00388
Gnomad ASJ exome
AF:
0.00248
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00320
Gnomad FIN exome
AF:
0.0534
Gnomad NFE exome
AF:
0.0140
Gnomad OTH exome
AF:
0.00994
GnomAD4 exome
AF:
0.0123
AC:
18007
AN:
1461440
Hom.:
178
Cov.:
30
AF XY:
0.0121
AC XY:
8792
AN XY:
727012
show subpopulations
Gnomad4 AFR exome
AF:
0.00209
Gnomad4 AMR exome
AF:
0.00400
Gnomad4 ASJ exome
AF:
0.00214
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00342
Gnomad4 FIN exome
AF:
0.0481
Gnomad4 NFE exome
AF:
0.0128
Gnomad4 OTH exome
AF:
0.00994
GnomAD4 genome
AF:
0.0106
AC:
1620
AN:
152288
Hom.:
34
Cov.:
33
AF XY:
0.0124
AC XY:
924
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.00221
Gnomad4 AMR
AF:
0.00314
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00290
Gnomad4 FIN
AF:
0.0558
Gnomad4 NFE
AF:
0.0125
Gnomad4 OTH
AF:
0.00900
Alfa
AF:
0.0113
Hom.:
16
Bravo
AF:
0.00692
TwinsUK
AF:
0.0111
AC:
41
ALSPAC
AF:
0.0132
AC:
51
ESP6500AA
AF:
0.00278
AC:
11
ESP6500EA
AF:
0.0127
AC:
106
ExAC
AF:
0.0120
AC:
1449
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0136
EpiControl
AF:
0.0130

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxJul 09, 2018- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2024PIGN: BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 11, 2017- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 21, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
PIGN-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 23, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.060
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.32
T;.;T;T;T;.;.;.;.;T;.;.;T;.;T;.;.;.;.;.;.;.;.;.;T;T;T;.;T
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.83
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
.;.;.;.;.;.;D;.;D;.;D;D;.;D;D;D;D;.;.;D;D;D;D;D;.;D;D;D;D
MetaRNN
Benign
0.012
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.083
D
MutationAssessor
Pathogenic
3.1
M;.;M;M;M;.;.;.;.;M;.;.;M;.;M;.;.;.;.;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-3.8
.;.;.;D;.;.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
0.76
Sift
Pathogenic
0.0
.;.;.;D;.;.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
0.011
.;.;.;D;.;.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.
Polyphen
1.0
D;.;D;D;D;.;.;.;.;D;.;.;D;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.31, 0.33
MPC
0.20
ClinPred
0.039
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.75
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61755362; hg19: chr18-59828420; API